Related Experiment Video
Updated: May 8, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Topical and biologic therapies for diabetic foot ulcers
Nicholas A Richmond1, Alejandra C Vivas, Robert S Kirsner
1Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Abstract:
Chronic DFUs are a growing global health concern due to the implied high rates of morbidity and mortality. Standard-of-care modalities sometimes are not sufficient for some recalcitrant ulcers. The use of adjuvant topical therapies including advanced dressings and biologic therapies should be considered in patients whose DFU did not reduce in size after receiving standard care for a period of 4 weeks. These advanced treatments must be used in combination with standard care measures, including debridement, moist wound healing, offloading, and infection control.
Related Concept Videos
Diabetic Foot Ulcer
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Peripheral Artery Disease IV: Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care